Omzo vs Oak Longevity: Semaglutide & Tirzepatide Compared
Looking for a direct comparison of Omzo vs Oak Longevity for online GLP-1 access? Quick verdict: Omzo emphasizes clinician-guided plans and offers compounded semaglutide starting at $179, while Oak Longevity focuses on lower flat pricing with semaglutide from $133/month and no subscription required.
See Omzo clinician-guided plans
How Omzo and Oak Longevity differ at a glance
This comparison uses only supplied facts. Both platforms offer access to GLP-1 medications including semaglutide and tirzepatide. Key differences are: pricing model and starting price, clinical pathway and review process, compounded medication disclosures, and shipping and membership terms.
Early distinctions
Omzo: personalized compounded semaglutide with clinician-guided plans, starting at $179; Omzo connects you with licensed U.S. providers who may use a compounded medication program. Oak Longevity: semaglutide from $133/month and tirzepatide from $199/month, one flat price for all dosages, no subscriptions, free shipping and free health coaching.
| Criteria | Omzo | Oak Longevity |
|---|---|---|
| Starting price | $179 (semaglutide) | $133/month (semaglutide) |
| Medication types offered | Compounded semaglutide & tirzepatide; branded prescriptions may be written | Compounded semaglutide & tirzepatide |
| Clinical review model | Clinician-guided plans reviewed by licensed U.S. providers; providers determine eligibility | Licensed physicians review cases in your state; no video call required and review is asynchronous |
| Pricing model and billing | Personalized plans; starting prices listed; further details and renewal terms may vary | One flat price covers all dosages; billed monthly on a non-recurring basis with no subscription |
| Shipping and extras | Fast, discreet delivery; FSA & HSA eligible noted | Free shipping with tracking; free health coaching included |
| Regulatory note | Compounded medications offered are not FDA-approved | Compounded medications are not FDA-approved |
Clinical pathway and oversight compared
Omzo emphasizes clinician-guided care with licensed U.S. providers reviewing plans and making final prescribing decisions. The platform notes clinical services are provided by third party networks of U.S.-licensed clinicians and that providers determine eligibility for GLP-1 treatment based on medical history and provider assessment. Oak Longevity states that board-certified physicians in your state review every case and that no video call or insurance is required; review is often asynchronous.
Check Oak Longevity pricing and review process
Pricing structure and transparency
Omzo lists semaglutide starting at $179 and tirzepatide starting at $279 and describes personalized, clinician-guided plans where medication costs are included in fees collected. Omzo also states that branded prescriptions may be written but Omzo does not sell or ship branded medications. Oak Longevity advertises semaglutide from $133/month and tirzepatide from $199/month with one flat price covering all dosages, no subscriptions, and no membership fees. Oak notes three-month prescriptions are billed upfront and that billing is non-recurring unless you choose to renew.
Compounded medications and regulatory notes
Both providers offer access to compounded GLP-1 medications and include the same regulatory qualifier: compounded medications are not FDA-approved and are not reviewed by FDA for safety, effectiveness, or quality. Omzo adds that its compounded medications are prepared and shipped by a state-licensed sterile compounding pharmacy and that these products have not been evaluated by the FDA. Oak Longevity likewise discloses that compounded versions are prepared by licensed compounding pharmacies.
Shipping, coaching, and membership differences
Oak Longevity highlights free shipping with tracking, free health coaching included, and no subscription or membership fees. Oak also notes same-day approval is available for qualifying patients and that the process does not require a video call. Omzo highlights fast, discreet delivery and notes FSA and HSA eligibility for its plans, while emphasizing clinician-guided plans reviewed by licensed providers. Specific state availability, eligibility, and renewal terms may change for both providers and readers should confirm before enrolling.
Final comparison and who each provider suits
Omzo vs Oak Longevity shows a fundamental trade-off: Omzo centers on clinician-guided, personalized plans with compounded options starting at $179 and the potential for branded prescriptions to be written, while Oak Longevity centers on lower flat pricing from $133/month, free shipping, and no subscription model. Both caution that compounded medications are not FDA-approved and that providers make the final determination on eligibility and prescribing.
Visit Oak Longevity to review offers
Choose Omzo if…
You want clinician-guided GLP-1 care reviewed by licensed U.S. providers, are comfortable with personalized plans that may include compounded medication or a branded prescription written for you, and want a program that notes FSA and HSA eligibility. Verify pricing, eligibility, renewal terms, and state availability before enrollment.
Choose Oak Longevity if…
You are cost-conscious and prefer a one-price-for-all-dosages model with semaglutide from $133/month, free shipping and health coaching, no subscription or membership fees, and an asynchronous review without a required video call. Confirm BMI eligibility rules and billing terms before starting.
Start with Omzo clinician-guided options
This comparison used only the supplied source facts for Omzo and Oak Longevity. Primary keyword: Omzo vs Oak Longevity.